Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H18N2O3.ClH |
Molecular Weight | 298.765 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN(CC)CCN1C(=O)OC2=C(C=CC=C2)C1=O
InChI
InChIKey=QPFDPUCWRFYCFB-UHFFFAOYSA-N
InChI=1S/C14H18N2O3.ClH/c1-3-15(4-2)9-10-16-13(17)11-7-5-6-8-12(11)19-14(16)18;/h5-8H,3-4,9-10H2,1-2H3;1H
Molecular Formula | C14H18N2O3 |
Molecular Weight | 262.3043 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Letimide is a new analgesic. It is a cyclic derivative of a salicylamide. The analgesic effect of this drug as determined in rats showed a higher potency than aspirin, but was without anti-inflammatory and antipyretic activity. Letimide is not a genotoxic agent according to the cytogenetic damage observed in vivo and in vitro, and would seem to justify other preclinical and clinical studies to confirm its lack of toxicity. Known adverse effects are headache and dizziness.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2017790
30, 50 and 100 mg/kg
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:45:29 GMT 2023
by
admin
on
Fri Dec 15 18:45:29 GMT 2023
|
Record UNII |
VDU2239C1V
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C170112
Created by
admin on Fri Dec 15 18:45:29 GMT 2023 , Edited by admin on Fri Dec 15 18:45:29 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110855
Created by
admin on Fri Dec 15 18:45:29 GMT 2023 , Edited by admin on Fri Dec 15 18:45:29 GMT 2023
|
PRIMARY | |||
|
DTXSID90176203
Created by
admin on Fri Dec 15 18:45:29 GMT 2023 , Edited by admin on Fri Dec 15 18:45:29 GMT 2023
|
PRIMARY | |||
|
172992
Created by
admin on Fri Dec 15 18:45:29 GMT 2023 , Edited by admin on Fri Dec 15 18:45:29 GMT 2023
|
PRIMARY | |||
|
VDU2239C1V
Created by
admin on Fri Dec 15 18:45:29 GMT 2023 , Edited by admin on Fri Dec 15 18:45:29 GMT 2023
|
PRIMARY | |||
|
21791-39-9
Created by
admin on Fri Dec 15 18:45:29 GMT 2023 , Edited by admin on Fri Dec 15 18:45:29 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |